CDC Stats Reveal Masks Are NOT Effective

CDC Stats Reveal Masks Are NOT Effective

Fascinating facts from the CDC concerning masks 😷 70.6% of people diagnosed with Covid ALWAYS wore a mask. Vs 3.9% of people who NEVER did. And yet, a top health official says that cloth/paper facemask may be more effective than the fast tracked abortion tainted vaccine is presently being tried on humans.

That Centers for Disease Control report released in September showed that masks and face coverings are not effective in preventing the spread of COVID-19, even for those people who consistently wear them.

A study conducted in the United States in July found that when they compared 154 “case-patients,” who tested positive for COVID-19, to a control group of 160 participants from the same health care facility who were symptomatic but tested negative, over 70 percent of the case-patients were contaminated with the virus and fell ill despite “always” wearing a mask.

“In the 14 days before illness onset, 71% of case-patients and 74% of control participants reported always using cloth face coverings or other mask types when in public,” the report stated.

In addition, over 14 percent of the case-patients said they “often” wore a face covering and were still infected with the virus. The study also demonstrates that under 4 percent of the case-patients became sick with the virus even though they “never” wore a mask or face covering.

Despite over 70 percent of the case-patient participants’ efforts to follow CDC recommendations by committing to always wearing face coverings at “gatherings with ≤10 or >10 persons in a home; shopping; dining at a restaurant; going to an office setting, salon, gym, bar/coffee shop, or church/religious gathering; or using public transportation,” they still contracted the virus.

How FACINATING it is that even though this statistical data is available – the ineffective masks are thought to be MORE effective than the fast tracked vaccines currently in human trials.

Rushed abortion contaminated vaccine now in human trials

Human trials are taking place on a rushed and minimally tested vaccine. Now the AAP is pressing for children, pregnant mothers, and people with underlying health conditions be added to the list of test subjects. Are these people receiving true informed consent? Do they have any idea of the ingredients and how they can impact the body separately let alone combined with other toxic ingredients?
We wonder if these human test subjects know that the injection they are receiving may be manufactured using cells derived from human fetuses?

At least five of the candidate COVID-19 vaccines use one of two human fetal cell lines: HEK-293, a kidney cell line widely used in research and industry that comes from a fetus aborted in about 1972; and PER.C6, a proprietary cell line owned by Janssen, a subsidiary of Johnson & Johnson, developed from retinal cells from an 18-week-old fetus aborted in 1985.

Baby Jaxon was born at 18 weeks – much too early is the same age as the child aborted and used in the vaccines for COVID
Walter Joshua Fretz who lived 19 weeks in the womb. Is only ONE WEEK OLDER than the preborn human aborted and used in the COVID vaccine Credit: Lexi Fretz & F2 Photography

Both cell lines were developed in the lab of molecular biologist Alex van der Eb at Leiden University. Two of the five vaccines have entered human trials (see table, below).

DeveloperVaccine typeFetal cells usedHuman trialsPotential U.S. fundingWarp Speed pick
DeveloperVaccine typeFetal cells usedHuman trialsPotential U.S. fundingWarp Speed pick
CanSino Biologics, Inc./Beijing Institute of BiotechnologyReplication-deficient adenovirusHEK-293Yes (phase II)NoNo
University of Oxford/AstraZenecaReplication-deficient adenovirusHEK-293Yes (phase II/III)$1.2 billionYes (short list*)
Janssen Research & Development USAReplication-deficient adenovirusPER.C6No$456 millionYes (short list*)
University of PittsburghProtein subunitHEK-293NoNoNo
ImmunityBio/NantKwestReplication-deficient adenovirusHEK-293 or derivative E.C7NoNoYes (long list)


In four of the vaccines, the human fetal cells are used as miniature “factories” to generate vast quantities of adenoviruses, disabled so that they cannot replicate, that are used as vehicles to ferry genes from the novel coronavirus that causes COVID-19. When the adenoviruses are given as a vaccine, recipients’ cells begin to produce proteins from the coronavirus, hopefully triggering a protective immune response.

The fifth vaccine, which has shown promise in monkeys and is headed for human trials as soon as this summer, is what is known as a protein subunit vaccine. Researchers at the University of Pittsburgh use HEK-293 cells to manufacture the coronavirus’ spike protein—a vital part of its structure—which is used to trigger an immune response. The vaccine is delivered through a skin patch with 400 tiny needles.

The fetal cell lines are key to producing both types of vaccine. “HEK-293 [cells] are essential for making protein subunit vaccines,” says Andrea Gambotto, a vaccine scientist at the University of Pittsburgh School of Medicine and the vaccine’s lead developer. Their human origin is important, he says: “Cultured [nonhuman] animal cells can produce the same proteins, but they would be decorated with different sugar molecules, which—in the case of vaccines—runs the risk of failing to evoke a robust and specific immune response.” (Among the developers of the five vaccines, only Gambotto responded to a request for comment.)

David Prentice, vice president and research director at the Charlotte Lozier Institute, which opposes abortion, notes researchers making adenovirus vaccines have modified HEK-293 cells to be adept at packaging new genes—such as those that direct cells to assemble the coronavirus spike protein—into adenoviruses. But he adds that other technologies are available, including using cells captured from amniocentesis that are engineered to make replication-deficient adenoviruses. (read more here)

American Academy of Pediatrics wants children to be part of COVID-19 vaccine experimentation

The American Academy of Pediatrics (AAP) is asking federal officials to include children in COVID-19 vaccine trials.1 On September 29, 2020, Sara Goza, MD, president of the AAP, wrote a letter addressed to U.S. Department of Health and Human Services (HHS) Secretary Alex Azar and Food and Drug Administration (FDA) Commissioner Steven Hahn, MD stating, “Children must be included in vaccine trials to best understand any potential unique immune responses and/or unique safety concerns.”2

Currently, none of the COVID-19 vaccines in clinical development are being tested in children under the age of 18 years.3

The letter goes on to state, “It would also be less than desirable to have one or more SARS-CoV-2 vaccines licensed or available under Emergency Use Authorization (EUA) at a time when no data have been collected on the safety, tolerability, dose, and regimen for children.”4

The AAP is also asking federal officials to include individuals in the trials who reflect the racial and ethnic diversity of the U.S. population and include pregnant women and individuals with underlying poor health conditions.5 (read full article here)


Leave a Reply